Optimal Intrathecal Morphine Dose for Better Post Cesarean Section Analgesia (Analgesia)
Comparison of Postoperative Analgesia With Different Doses of Intrathecal Morphine With Hyperbaric Bupivacaine and Fentanyl in Cesarean Section Patients: A Randomized Controlled Trial
Central neuraxial blocks (CNBs) remain the preferred anesthetic technique for cesarean section, with single shot spinal anesthesia (SSSA) being the standard practice at investigator's institute unless contraindicated. SSSA offers reliable intraoperative anesthesia and provides a few hours of postoperative analgesia. Enhanced recovery after cesarean section protocol has recommended the addition of intrathecal (IT) morphine to improve the postoperative quality of the recovery profile. Fentanyl improves the quality of intraoperative analgesia, while morphine significantly prolongs the postoperative pain relief, often lasting up to 24 hours.
Routine uterine exteriorization, practiced in all cases at investigator's institute, often results in peritoneal stretching pain during surgery. This visceral pain is managed with 10 mcg intrathecal fentanyl added to hyperbaric bupivacaine. For postoperative pain management, the intrathecal morphine is recommended by many guidelines and studies. Intrathecal morphine dose typically ranges from 50 to 300 mcg. The dose of morphine exceeding 150 mcg are usually associated with prolongation of analgesia with higher incidence of side effects like nausea, vomiting and pruritus. In selected cases, investigator had administered morphine 100-150 mcg and the clinical experience has shown reduced postoperative analgesic requirements and favorable recovery profile, with minimal adverse effects.
Despite these promising experiences and extensive literature on IT morphine, their is still lack formal data on the efficacy and safety profile of IT morphine in cesarean section patient. This comparative study will help institute to find the optimum dose of IT morphine with better postoperative analgesia quality with low side effects profile. The finding could serve as a foundation to promote routine use of intrathecal morphine in cesarean section anesthesia at investigator's institute.
연구 개요
상태
정황
연구 유형
등록 (추정된)
단계
- 4단계
연락처 및 위치
연구 연락처
- 이름: Bashu Dev Parajuli, MD Anaesthesiology
- 전화번호: 00977+ 9851179038
- 이메일: bashuparajuli2012@gmail.com
연구 연락처 백업
- 이름: Pooja Poudyal, MD Obstetric and Gynaecology
- 전화번호: 00977+9841526853
- 이메일: paudyalpooja@yahoo.com
참여기준
자격 기준
공부할 수 있는 나이
- 성인
건강한 자원 봉사자를 받아들입니다
설명
Inclusion Criteria:
- Pregnant lady > 36 weeks of gestation presenting for cesarean section under spinal anesthesia
- ASA II/ III
- Maternal Height > 150 cm
- BMI< 40 Kg/m2
- Elective Indication
Exclusion Criteria:
- Patient unwilling to take part in the study
- Patient with known allergy to the study medications
- Contraindication to Spinal Anesthesia
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 삼루타
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
활성 비교기: Group BF
Intrathecal drug used: 0.5% hyperbaric bupivacaine 10mg(2ml) with fentanyl 10mcg(0.2ml),
total volume of 2.2ml, single administration, no repetition of intervention In this group, no dose of morphine will be added.
|
Spinal anesthesia with 0.5% bupivacaine heavy with fentanyl at L3-L4 intervertebral space using Quincke's spinal needle in sitting position in patients undergoing cesarean section to study the dose with better analgesia profile and lower side effect profile.
|
|
실험적: Group BF-M50
Intrathecal drug used : 0.5% hyperbaric bupivacaine 10mg(2ml) with fentanyl 10mcg(0.2ml)
plus morphine 50mcg (0.05ml) with total volume of 2.25ml single administration, no repetition of intervention
|
Spinal anesthesia with 0.5% bupivacaine heavy with fentanyl with morphine 50mcg at L3-L4 intervertebral space using Quincke's spinal needle in sitting position in patients undergoing cesarean section to study the dose with better analgesia profile and lower side effect profile.
|
|
실험적: Group BF-M100
Intrathecal drug used : 0.5% hyperbaric bupivacaine 10mg(2ml) with fentanyl 10mcg(0.2ml)
plus morphine 100mcg (0.1ml) with total volume of 2.3ml single administration, no repetition of intervention
|
Spinal anesthesia with 0.5% bupivacaine heavy with fentanyl with morphine 100mcg at L3-L4 intervertebral space using Quincke's spinal needle in sitting position in patients undergoing cesarean section to study the dose with better analgesia profile and lower side effect profile.
|
|
실험적: Group BF-M150
Intrathecal drug used : 0.5% hyperbaric bupivacaine 10mg(2ml) with fentanyl 10mcg(0.2ml)
plus morphine 150mcg (0.15ml) with total volume of 2.35ml single administration, no repetition of intervention
|
Spinal anesthesia with 0.5% bupivacaine heavy with fentanyl with morphine 150mcg at L3-L4 intervertebral space using Quincke's spinal needle in sitting position in patients undergoing cesarean section to study the dose with better analgesia profile and lower side effect profile.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
To compare the incidence of postoperative pain after cesarean section with different doses of intrathecal morphine with bupivacaine among the four groups.
기간: NRS score is measured in recovery room for postoperative pain assessment. This time will be recorded as "time zero". Then in postoperative ward, NRS score is measured at 2 hours, 4 hours, 6 hours, 12 hours and 24 hours from 'time zero".
|
The parturient among study groups receiving different dose of intrathecal morphine with bupivacaine were compared for incidence of postoperative cesarean section pain.
The pain is assessed by using Numerical Pain Rating Scale(NRS) ,a 11-point, standardized tool (0-10) in which 0 means "no pain" and 10 means "the worst pain imaginable".
The number of parturient with NRS more than 3 will be compared for postoperative pain among the 4 groups.
|
NRS score is measured in recovery room for postoperative pain assessment. This time will be recorded as "time zero". Then in postoperative ward, NRS score is measured at 2 hours, 4 hours, 6 hours, 12 hours and 24 hours from 'time zero".
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
To compare the first rescue analgesia demand time among the four groups
기간: Postoperative period after cesarean delivery till 24 hour
|
Rescue analgesia demand is defined as the first time after the cesarean section when the NRS score > 3, and analgesic will be needed.
The time period after cesarean section when first rescue analgesic is needed will be compared among the four group.
Inj.Ketorolac 30 mg iv will be supplemented first as rescue analgesic and recorded.
|
Postoperative period after cesarean delivery till 24 hour
|
|
To compare the total analgesic consumption in first 24 hours among the parturient of four group
기간: Postoperative total analgesia consumption for first 24 hour
|
Total analgesia consumption is defined as the total amount of paracetamol, ketorolac and tramadol received in the first 24 hours.
From the time of first dose of ketorolac, regular analgesia will be prescribed as inj.
ketorolac 30mg iv 8 hourly and inj.
paracetamol 1gm iv 6 hourly for 24 hour.
If the NRS score >3 at any point of time apart from the regular above medication, then Inj.
tramadol 50 mg iv SOS will be provided and recorded.
The number pf parturient with total analgesics consumption in 24 hour will be compared among the four groups.
|
Postoperative total analgesia consumption for first 24 hour
|
|
To compare the frequency of rescue analgesia demanded by parturient in first 24 hours among the groups
기간: Postoperative period for first 24 hour
|
Frequency of rescue analgesia demand is measured by number of time patient with NRS >3 who demand for iv ketorolac, paracetamol and tramadol despite providing regular analgesia (inj ketorolac 30mg iv 8 hourly and inj.paracetamol 1gm iv 6 hourly) for 24 hour.
|
Postoperative period for first 24 hour
|
|
To compare the incidence of side effects like nausea, vomiting, respiratory depression, level of sedation and pruritus in first 24 hours among the groups
기간: Postoperative period for first 24 hour
|
Number of parturient with treatment related side effects like nausea, vomiting, pruritus, respiratory depression and level of sedation are assessed and compared among the groups. Level of sedation is assessed by Pasero Opioid - Induced Sedation Scale (POSS) This score consist: of : S Sleepy, easy to arouse
|
Postoperative period for first 24 hour
|
공동 작업자 및 조사자
간행물 및 유용한 링크
일반 간행물
- Sultan P, Halpern SH, Pushpanathan E, Patel S, Carvalho B. The Effect of Intrathecal Morphine Dose on Outcomes After Elective Cesarean Delivery: A Meta-Analysis. Anesth Analg. 2016 Jul;123(1):154-64. doi: 10.1213/ANE.0000000000001255.
- Choudhury M. Neuraxial anaesthesia in parturient with cardiac disease. Indian J Anaesth. 2018 Sep;62(9):682-690. doi: 10.4103/ija.IJA_474_18.
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- IRC/IOM/D-2026-339
- NHRC 772-2025 (기타 식별자: NHRC)
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
미국에서 제조되어 미국에서 수출되는 제품
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .